These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23348551)
21. Improving the global care of familial hypercholesterolaemia: Starting the ball rolling. Ray KK; Watts GF Atherosclerosis; 2018 Oct; 277():230-233. PubMed ID: 30270053 [No Abstract] [Full Text] [Related]
22. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
24. [Biological efficacy of LDL apheresis in major hypercholesterolemia]. Dairou F; Assogba U; Bruckert E; De Gennes JL; Turpin G Ann Med Interne (Paris); 1994; 145(5):328-32. PubMed ID: 7985942 [TBL] [Abstract][Full Text] [Related]
25. A European screening programme for familial hypercholesterolaemia: a call to action. Gielen S; Weingärtner O Eur J Prev Cardiol; 2024 Aug; 31(10):1199-1202. PubMed ID: 36718096 [No Abstract] [Full Text] [Related]
31. A boy with autosomal recessive hypercholesterolaemia. Rodenburg J; Wiegman A; Vissers MN; Kastelein JJ; Stalenhoef AF Neth J Med; 2004 Mar; 62(3):89-93. PubMed ID: 15209474 [TBL] [Abstract][Full Text] [Related]
32. Long term treatment of two familial hypercholesterolemic heterozygote patients with batch affinity chromatography (BAC). Lupien PJ; Moorjani S; Gagne C; Brun LD; Lou M; Dagenais G Artery; 1982; 10(4):286-300. PubMed ID: 7181673 [TBL] [Abstract][Full Text] [Related]
33. Cutaneous manifestations of familial hypercholesterolaemia. Meher D; Dutta D; Misgar RA Postgrad Med J; 2016 May; 92(1087):304-5. PubMed ID: 26739848 [No Abstract] [Full Text] [Related]
34. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods]. Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708 [TBL] [Abstract][Full Text] [Related]
35. Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia. Minhas R; Humphries SE; Qureshi N; Neil HA; Heart; 2009 Apr; 95(7):584-7; discussion 587-91. PubMed ID: 19168470 [No Abstract] [Full Text] [Related]
36. Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes. Cuthbert JA; East CA; Bilheimer DW; Lipsky PE N Engl J Med; 1986 Apr; 314(14):879-83. PubMed ID: 3633381 [TBL] [Abstract][Full Text] [Related]
37. Editor's Note: Relates to: 'Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society '. Eur Heart J; 2020 Dec; 41(47):4517. PubMed ID: 32167556 [No Abstract] [Full Text] [Related]
38. Activity of thrombocytes as a marker of sufficient intensity of LDL-apheresis in familial hypercholesterolaemia. Blaha M; Pecka M; Urbankova J; Blaha V; Maly J; Zadak Z; Blazek M Transfus Apher Sci; 2004 Apr; 30(2):83-7. PubMed ID: 15062743 [TBL] [Abstract][Full Text] [Related]